tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AU:TYP

Tryptamine Therapeutics Issues New Shares in Compliance with Corporations Act
Company AnnouncementsTryptamine Therapeutics Issues New Shares in Compliance with Corporations Act
1M ago
TYP
Tryptamine Therapeutics Lists New Securities on ASX
PremiumCompany Announcements
Tryptamine Therapeutics Lists New Securities on ASX
1M ago
TYP
Tryptamine Therapeutics Advances World-First Trial for Binge Eating Disorder
PremiumCompany Announcements
Tryptamine Therapeutics Advances World-First Trial for Binge Eating Disorder
1M ago
TYP
Tryptamine Therapeutics Advances Clinical Trials and Holds Successful AGM
PremiumCompany Announcements
Tryptamine Therapeutics Advances Clinical Trials and Holds Successful AGM
1M ago
TYP
Tryptamine Therapeutics Announces Cessation of Securities
PremiumCompany Announcements
Tryptamine Therapeutics Announces Cessation of Securities
1M ago
TYP
Tryptamine Therapeutics Updates Quarterly Activities Report with Key Clinical Advances
PremiumCompany AnnouncementsTryptamine Therapeutics Updates Quarterly Activities Report with Key Clinical Advances
1M ago
TYP
Tryptamine Therapeutics Expands Market Presence with New Securities Issuance
Premium
Company Announcements
Tryptamine Therapeutics Expands Market Presence with New Securities Issuance
1M ago
TYP
Tryptamine Therapeutics Announces Proposed Securities Issue
Premium
Company Announcements
Tryptamine Therapeutics Announces Proposed Securities Issue
1M ago
TYP
Tryptamine Therapeutics Announces Major Securities Issue
PremiumCompany Announcements
Tryptamine Therapeutics Announces Major Securities Issue
1M ago
TYP
Tryptamine Therapeutics Secures $6.1 Million to Advance TRP-8803 Clinical Trials
PremiumCompany Announcements
Tryptamine Therapeutics Secures $6.1 Million to Advance TRP-8803 Clinical Trials
1M ago
TYP
Tryptamine Therapeutics Initiates Trading Halt for Capital Raising
PremiumCompany Announcements
Tryptamine Therapeutics Initiates Trading Halt for Capital Raising
2M ago
TYP
Tryptamine Therapeutics Advances World-First Clinical Trial for Binge Eating Disorder
PremiumCompany Announcements
Tryptamine Therapeutics Advances World-First Clinical Trial for Binge Eating Disorder
2M ago
TYP
Tryptamine Therapeutics Updates AGM Notice with New Auditor Appointment
PremiumCompany AnnouncementsTryptamine Therapeutics Updates AGM Notice with New Auditor Appointment
2M ago
TYP
Tryptamine Therapeutics to Present at Microcap Investment Conference
Premium
Company Announcements
Tryptamine Therapeutics to Present at Microcap Investment Conference
2M ago
TYP
Tryptamine Therapeutics Initiates Pioneering Trial for Binge Eating Disorder
Premium
Company Announcements
Tryptamine Therapeutics Initiates Pioneering Trial for Binge Eating Disorder
2M ago
TYP
Tryptamine Therapeutics Announces 2025 AGM and Advances in Clinical Trials
PremiumCompany Announcements
Tryptamine Therapeutics Announces 2025 AGM and Advances in Clinical Trials
2M ago
TYP
Tryptamine Therapeutics Announces Cessation of Securities
PremiumCompany Announcements
Tryptamine Therapeutics Announces Cessation of Securities
3M ago
TYP
Tryptamine Therapeutics Announces 2025 AGM Date and Advances in Clinical Trials
PremiumCompany Announcements
Tryptamine Therapeutics Announces 2025 AGM Date and Advances in Clinical Trials
3M ago
TYP
Tryptamine Therapeutics Showcases TRP-8803 at Neuropsychiatric Summit
PremiumCompany Announcements
Tryptamine Therapeutics Showcases TRP-8803 at Neuropsychiatric Summit
3M ago
TYP
Tryptamine Therapeutics Issues New Securities on ASX
PremiumCompany AnnouncementsTryptamine Therapeutics Issues New Securities on ASX
3M ago
TYP
Tryptamine Therapeutics Releases 2025 Corporate Governance Statement
Premium
Company Announcements
Tryptamine Therapeutics Releases 2025 Corporate Governance Statement
4M ago
TYP
Tryptamine Therapeutics Reports Increased Income and Reduced Losses
Premium
Company Announcements
Tryptamine Therapeutics Reports Increased Income and Reduced Losses
4M ago
TYP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >